North China Pharmaceutical Group Corporation
North China Pharmaceutical Group Corporation
North China Pharmaceutical Group Co., Ltd. (hereinafter referred to as Hua Pharmaceutical Group) is located in Shijiazhuang, the capital of Hebei Province. The predecessor of North China Pharmaceutical Factory was a key construction project during China's "First Five-Year Plan" period. It was started in June 1953 and completed and put into production in June 1958. It has created a history of large-scale antibiotic production in my country, and has been used for the development of human health and the national pharmaceutical industry. It has made important contributions to changing the situation of shortage of doctors and drugs in my country. In 1992, it was reorganized and established North China Pharmaceutical Co., Ltd., and was listed on the Shanghai Stock Exchange in 1994 (stock name: North China Pharmaceutical 600812). In January 1996, North China Pharmaceutical Factory was officially reorganized into a wholly state-owned company - North China Pharmaceutical Group Co., Ltd. In June 2009, with the approval of the Hebei Provincial Government, Jizhong Energy Group implemented a restructuring of Hua Pharmaceutical Group.
Over the years, Huayao Group has adhered to the corporate purpose of "human health first, quality always comes first", continuously innovated, operated steadily, gradually expanded its business scope, maintained excellent development performance, and its main economic and technical indicators have always been at the forefront of the domestic industry. . As of the end of 2018, Huayao Group had a total assets of 20.6 billion yuan, nearly 15,000 employees, and more than 40 subsidiaries (branches) companies, including the National Engineering Research Center for Microbial Drugs, the National Key Laboratory for Antibody Drug Development, Antibiotic Enzyme Catalysis and Crystallization technology, the three innovative platforms of the National and Local Joint Engineering Laboratory, mainly include nearly a thousand product specifications in the fields of chemical pharmaceuticals, modern biotechnology drugs, vitamins and nutritional health products, modern Chinese medicine, biological agricultural and veterinary medicine, etc. The treatment field covers anti-infection categories , cardiovascular, kidney disease, anti-tumor and immunomodulation, etc. The process routes and production layout of the main production units are all designed and implemented in accordance with the current European and American versions and the new Chinese version of GMP standards, and have a modern pharmaceutical production platform with international advanced standards.
Brand: FOSHAN PHARMA
Main Products: Tetanus Antitoxin Injection , Tetanus Antiserum , Human Hepatitis B Immunoglobulin , Oxytocin Injection , Natural essential oil , Biological Product For Human
Shaanxi YXchuang Biotechnology Co., Ltd
Brand: YXchuang
Main Products: API Powder , Pharmaceutical Intermediates , Vitamins Powder , Plant Extracts , Food Additive , Peptide Powder
Brand: NOUVASANT
Main Products: Finished Pharmaceutical Product , API & Raw materials , Antimalarial , Antibiotic & Antimicrobial , Medical Disposables , Antifungal Drugs
NANYANG CHENGPENG PHARMACEUTICAL CO.,LTD
Brand: CHENGPENG
Main Products: Veterinary APIS , Veterinary Premix APIs , Veterinary Soluble Powder , Feed Additives , Food Additives , Extracts for Animal
Brand: ERA Medicals
Main Products: Medical Instruments , Medicinal Materials , Pharmaceutical Accessories , Medical Disposables , Pharmaceutical Excipients , Medical Supplies
